Sign In
Buy EGRX
$0.460
+0 (+0%)
At Close: Jun 03, 2026
Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX): What Does Its Beta Value Mean For Your Portfolio?
01:25pm, Tuesday, 07'th Apr 2020
Anyone researching Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) might want to consider the historical volatility of the...
Eagle Pharmaceuticals (NASDAQ:EGRX) Stock Price Up 8.7%
07:02am, Tuesday, 07'th Apr 2020
Eagle Pharmaceuticals Inc (NASDAQ:EGRX) rose 8.7% during mid-day trading on Monday . The stock traded as high as $47.42 and last traded at $47.33, approximately 136,138 shares changed hands during mid
Goldman Sachs Group Inc. Raises Stock Holdings in Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
09:44am, Monday, 06'th Apr 2020
Goldman Sachs Group Inc. increased its position in Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 103.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securi
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Reduces Position in Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
10:08am, Sunday, 05'th Apr 2020
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lessened its stake in shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 23.0% in the fourth quarter, HoldingsChannel.com reports.
Baird Financial Group Inc. Acquires 4,107 Shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
09:36am, Wednesday, 01'st Apr 2020
Baird Financial Group Inc. increased its holdings in shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 13.0% in the fourth quarter, according to its most recent disclosure with the SEC. The firm ow
Zacks: Analysts Expect Eagle Pharmaceuticals Inc (NASDAQ:EGRX) Will Post Quarterly Sales of $47.76 Million
08:16am, Wednesday, 01'st Apr 2020
Wall Street analysts predict that Eagle Pharmaceuticals Inc (NASDAQ:EGRX) will report $47.76 million in sales for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for Ea
Eagle Pharmaceuticals: SymBio completes enrollment in TREAKISYM trial EGRX
11:19am, Monday, 30'th Mar 2020
Eagle Pharmaceuticals: SymBio completes enrollment in TREAKISYM trial EGRX
Eagle Pharmaceuticals, Inc. ("Eagle" or the "Company") (NASDAQ: EGRX) today announced that its marketing partner SymBio Pharmaceuticals Limited ("SymBio") has completed patient enrollment in a clinica
AQR Capital Management LLC Increases Stock Position in Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
09:24am, Monday, 30'th Mar 2020
AQR Capital Management LLC lifted its holdings in shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 12.5% during the fourth quarter, according to its most recent 13F filing with the Securities and
Alberta Investment Management Corp Trims Position in Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
08:28am, Saturday, 28'th Mar 2020
Alberta Investment Management Corp lessened its stake in shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 40.4% during the 4th quarter, according to the company in its most recent filing with the
Envestnet Asset Management Inc. Sells 669 Shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
10:54am, Friday, 27'th Mar 2020
Envestnet Asset Management Inc. trimmed its holdings in shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 6.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities a
Read This Before Judging Eagle Pharmaceuticals, Inc.’s (NASDAQ:EGRX) ROE
01:27pm, Wednesday, 25'th Mar 2020
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Eagle Pharmaceuticals (EGRX) Gets a Buy Rating from RBC Capital
12:49pm, Wednesday, 25'th Mar 2020
RBC Capital analyst Randall Stanicky maintained a Buy rating on Eagle Pharmaceuticals (EGRX) today and set a price target of $59.00. The company's shares
Eagle Pharmaceuticals (EGRX) Gets a Buy Rating from RBC Capital
12:49pm, Wednesday, 25'th Mar 2020
RBC Capital analyst
Randall Stanicky
maintained a
Buy
rating on Eagle Pharmaceuticals (
EGRX
–
Research Report
) today and set a price target of
$59.00
. The company’s shares closed last Monday at
ProShare Advisors LLC Sells 525 Shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
10:12am, Tuesday, 24'th Mar 2020
ProShare Advisors LLC trimmed its position in shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 10.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchang
